Longeveron to Present at BIO International Convention 2026
Longeveron Inc. announced its participation at the BIO International Convention 2026, presenting new clinical data and exploring strategic partnerships for its stem cell therapy laromestrocel. The therapy targets serious conditions including Hypoplastic Left Heart Syndrome, Alzheimer’s disease, Pediatric Dilated Cardiomyopathy, and Aging-related Fr…